Status:
COMPLETED
Nanocytology Test to Evaluate Skin Cancer in High Risk Patients
Lead Sponsor:
Northwestern University
Conditions:
Actinic Keratosis
Squamous Cell Carcinoma
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The purpose of this study is to correlate pathological features from specimens in order to determine if this new molecular diagnostic technique can be used to detect risk of skin cancer.
Detailed Description
Squamous cell carcinoma is the culmination of a multistep carcinogenesis process that is preceded by early stages referred as squamous dysplasia and actinic keratosis. Squamous dysplasia (SD) also kno...
Eligibility Criteria
Inclusion
- 18 to 89 years old, male and female, Fitzpatrick skin phototype I - III
- Photodamage skin grades 3 - 4 (global assessment)
- Medical history of precancerous lesions and or known history of SCC or healthy volunteers
Exclusion
- Subjects under 18 years old
- Pregnant women or lactating mothers
- Treatment with systemic chemotherapy within 4 weeks period before consent
- Known HIV+ patients (self-reported)
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT01905891
Start Date
July 1 2013
End Date
November 1 2014
Last Update
November 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611